The kidney and hypolipidemic treatment

Abstract

Dyslipidemia which is frequently present in patients with chronic kidney diseases contributes to an increase of cardiovascular risk and progression of renal damage. Statins and fibrates are used in the treatment.

Keywords

• chronic kidney diseases
• dyslipidemia
• hypolipidemic drugs